Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1978 Aug;54(634):516–527. doi: 10.1136/pgmj.54.634.516

Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group.

A El-Ghobarey, G Balint, K de Ceulaer, W C Dick, W W Buchanan, T Hadidi, T A Hassan
PMCID: PMC2425292  PMID: 733682

Abstract

Seven young adults, six of whom were male, all suffering from dermatomyositis unassociated with malignancy are described. These patients were not adequately controlled with high doses of corticosteroids but all responded when immunosuppressive therapy was also given.

Full text

PDF
516

Images in this article

520Fig. 4
on p.520
520Fig. 5
on p.520

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNDELL F. D., WILKINSON R. D., HASERICK J. R. Dermatomyositis and malignant neoplasms in adults. A survey of twenty years' experience. Arch Dermatol. 1960 Nov;82:772–775. doi: 10.1001/archderm.1960.01580050114017. [DOI] [PubMed] [Google Scholar]
  2. Arnett F. C., Whelton J. C., Zizic T. M., Stevens M. B. Methotrexate therapy in polymyositis. Ann Rheum Dis. 1973 Nov;32(6):536–546. doi: 10.1136/ard.32.6.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BARWICK D. D., WALTON J. N. POLYMYOSITIS. Am J Med. 1963 Nov;35:646–660. doi: 10.1016/0002-9343(63)90136-0. [DOI] [PubMed] [Google Scholar]
  4. BRUNSTING L. A., CHRISTIANSON H. B., PERRY H. O. Dermatomyositis; unusual features, complications, and treatment. AMA Arch Derm. 1956 Dec;74(6):581–589. [PubMed] [Google Scholar]
  5. Babka J. C., Pepine C. J. Hyperkinetic cardiovascular state in polymyositis. Chest. 1973 Aug;64(2):243–246. doi: 10.1378/chest.64.2.243. [DOI] [PubMed] [Google Scholar]
  6. Bailin P. L., Tindall J. P., Roenigk H. H., Jr, Hogan M. D. Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis. JAMA. 1975 Apr 28;232(4):359–362. [PubMed] [Google Scholar]
  7. Barnes B. E., Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med. 1976 Jan;84(1):68–76. doi: 10.7326/0003-4819-84-1-68. [DOI] [PubMed] [Google Scholar]
  8. Bates D., Stevens J. C., Hudgson P. "Polymyositis" with involvement of facial and distal musculature. One form of the fascioscapulohumeral syndrome? J Neurol Sci. 1973 May;19(1):105–108. doi: 10.1016/0022-510x(73)90061-0. [DOI] [PubMed] [Google Scholar]
  9. Bohan A., Peter J. B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975 Feb 13;292(7):344–347. doi: 10.1056/NEJM197502132920706. [DOI] [PubMed] [Google Scholar]
  10. Burnet F. M. Immunological aspects of malignant disease. Lancet. 1967 Jun 3;1(7501):1171–1174. doi: 10.1016/s0140-6736(67)92837-1. [DOI] [PubMed] [Google Scholar]
  11. CURTIS A. C., BLAYLOCK H. C., HARRELL E. R., Jr Malignant lesions associated with dermatomyositis. J Am Med Assoc. 1952 Nov 1;150(9):844–846. doi: 10.1001/jama.1952.03680090008004. [DOI] [PubMed] [Google Scholar]
  12. Carpenter S., Karpati G., Rothman S., Watters G. The childhood type of dermatomyositis. Neurology. 1976 Oct;26(10):952–962. doi: 10.1212/wnl.26.10.952. [DOI] [PubMed] [Google Scholar]
  13. Chou S. M., Gutmann L. Picornavirus-like crystals in subacute polymyositis. Neurology. 1970 Mar;20(3):205–213. doi: 10.1212/wnl.20.3.205. [DOI] [PubMed] [Google Scholar]
  14. Chou S. M. Myxovirus-like structures and accompanying nuclear changes in chronic polymyositis. Arch Pathol. 1968 Dec;86(6):649–658. [PubMed] [Google Scholar]
  15. Copeman P. W., Alexander S. Dermatomyositis. Adenocarcinoma of male breast. Detection of antibodies to the neoplasm in the serum. Proc R Soc Med. 1967 Feb;60(2):183–185. doi: 10.1177/003591576706000234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Currie S., Walton J. N. Immunosuppressive therapy in polymyositis. J Neurol Neurosurg Psychiatry. 1971 Aug;34(4):447–452. doi: 10.1136/jnnp.34.4.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. DEMIS D. J., BROWN C. S., CROSBY W. H. THIOGUANINE IN THE TREATMENT OF CERTAIN AUTOIMMUNE, IMMUNOLOGIC AND RELATED DISEASES. Am J Med. 1964 Aug;37:195–205. doi: 10.1016/0002-9343(64)90005-1. [DOI] [PubMed] [Google Scholar]
  18. Dawkins R. L., Mastaglia F. L. Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med. 1973 Mar 1;288(9):434–438. doi: 10.1056/NEJM197303012880903. [DOI] [PubMed] [Google Scholar]
  19. DeVere R., Bradley W. G. Polymyositis: its presentation, morbidity and mortality. Brain. 1975 Dec;98(4):637–666. doi: 10.1093/brain/98.4.637. [DOI] [PubMed] [Google Scholar]
  20. Decker J. L. Toxicity of immunosuppressive drugs in man. Arthritis Rheum. 1973 Jan-Feb;16(1):89–91. doi: 10.1002/art.1780160115. [DOI] [PubMed] [Google Scholar]
  21. Denman A. M., Pelton B. K., Kinsley M., Knight S., Partridge C., Walker P., Bannister B., Gumpel M., Smith D. S., Loewi E. The treatment of connective tissue diseases with antilymphocyte globulin. Postgrad Med J. 1976;52(5 Suppl):118–122. [PubMed] [Google Scholar]
  22. Dubowitz V. Treatment of dermatomyositis in childhood. Arch Dis Child. 1976 Jul;51(7):494–500. doi: 10.1136/adc.51.7.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Esiri M. M., MacLennan I. C., Hazleman B. L. Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol. 1973 May;14(1):25–35. [PMC free article] [PubMed] [Google Scholar]
  24. Fernandes L., Swinson D. R., Hamilton E. B. Dermatomyositis complicating penicillamine treatment. Ann Rheum Dis. 1977 Feb;36(1):94–95. doi: 10.1136/ard.36.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fessel W. J. Muscle diseases in rheumatology. Semin Arthritis Rheum. 1973;3(2):127–154. doi: 10.1016/0049-0172(73)90008-5. [DOI] [PubMed] [Google Scholar]
  26. Filip D. J., Logue G. L., Harle T. S., Farrar W. H. Pulmonary and hepatic complications of methotrexate therapy of psoriasis. JAMA. 1971 May 3;216(5):881–882. [PubMed] [Google Scholar]
  27. Frazier A. R., Miller R. D. Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest. 1974 Apr;65(4):403–407. doi: 10.1378/chest.65.4.403. [DOI] [PubMed] [Google Scholar]
  28. Fruman L. S., Ragsdale C. G., Sullivan D. B., Petty R. E. Retinopathy in juvenile dermatomyositis. J Pediatr. 1976 Feb;88(2):267–269. doi: 10.1016/s0022-3476(76)80996-1. [DOI] [PubMed] [Google Scholar]
  29. Goldman G. C., Moschella S. L. Severe pneumonitis occurring during methotrexate therapy. Re- port of two cases. Arch Dermatol. 1971 Feb;103(2):194–197. [PubMed] [Google Scholar]
  30. HOLMES J. M. A case of acute dermatomyositis. Br Med J. 1948 Sep 11;2(4575):511–514. doi: 10.1136/bmj.2.4575.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Haas D. C., Arnason B. G. Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol. 1974 Sep;31(3):192–196. doi: 10.1001/archneur.1974.00490390074008. [DOI] [PubMed] [Google Scholar]
  32. Haas D. C. Treatment of polymyositis with immunosuppressive drugs. Neurology. 1973 Jan;23(1):55–62. doi: 10.1212/wnl.23.1.55. [DOI] [PubMed] [Google Scholar]
  33. Harrison S. M., Frenkel M., Grossman B. J., Matalon R. Retinopathy in childhood dermatomyositis. Am J Ophthalmol. 1973 Nov;76(5):786–790. doi: 10.1016/0002-9394(73)90578-3. [DOI] [PubMed] [Google Scholar]
  34. Hashimoto K., Robison L., Velayos E., Niizuma K. Dermatomyositis. Electron microscopic, immunologic, and tissue culture studies of paramyxovirus-like inclusions. Arch Dermatol. 1971 Feb;103(2):120–135. doi: 10.1001/archderm.103.2.120. [DOI] [PubMed] [Google Scholar]
  35. Hersh E. M., Wong V. G., Freireich E. J. Inhibition of the local inflammatory response in man by antimetabolites. Blood. 1966 Jan;27(1):38–48. [PubMed] [Google Scholar]
  36. Hurd E. R. Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate. Arthritis Rheum. 1973 Jan-Feb;16(1):84–88. doi: 10.1002/art.1780160114. [DOI] [PubMed] [Google Scholar]
  37. Jacobs J. C. Methotrexate and azathioprine treatment of childhood dermatomyositis. Pediatrics. 1977 Feb;59(2):212–218. [PubMed] [Google Scholar]
  38. Janis J. F., Winkelmann R. K. Histopathology of the skin in dermatomyositis. A histopathologic study of 55 cases. Arch Dermatol. 1968 Jun;97(6):640–650. [PubMed] [Google Scholar]
  39. Johnson R. L., Fink C. W., Ziff M. Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest. 1972 Sep;51(9):2435–2449. doi: 10.1172/JCI107057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kagen L. J., Kimball A. C., Christian C. L. Serologic evidence of toxoplasmosis among patients with polymyositis. Am J Med. 1974 Feb;56(2):186–191. doi: 10.1016/0002-9343(74)90596-8. [DOI] [PubMed] [Google Scholar]
  41. Krain L. Dermatomyositis in six patients without initial muscle involvement. Arch Dermatol. 1975 Feb;111(2):241–245. [PubMed] [Google Scholar]
  42. LAMBERT E. H., SAYRE G. P., EATON L. M. Electrical activity of muscle in polymyositis. Trans Am Neurol Assoc. 1954;13(79TH):64–69. [PubMed] [Google Scholar]
  43. LAMBIE J. A., DUFF I. F. FAMILIAL OCCURRENCE OF DERMATOMYOSITIS. CASE REPORTS AND A FAMILY SURVEY. Ann Intern Med. 1963 Dec;59:839–847. doi: 10.7326/0003-4819-59-6-839. [DOI] [PubMed] [Google Scholar]
  44. Leddy J. P., Griggs R. C., Klemperer M. R., Frank M. M. Hereditary complement (C2) deficiency with dermatomyositis. Am J Med. 1975 Jan;58(1):83–91. doi: 10.1016/0002-9343(75)90537-9. [DOI] [PubMed] [Google Scholar]
  45. Malaviya A. N., Many A., Schwartz R. S. Treatment of dermatomyositis with methotrexate. Lancet. 1968 Aug 31;2(7566):485–488. doi: 10.1016/s0140-6736(68)90649-1. [DOI] [PubMed] [Google Scholar]
  46. Marinacci A. A. Electromyography in the diagnosis of polymyositis. Electromyography. 1965 Oct-Dec;5(4):255–268. [PubMed] [Google Scholar]
  47. McFarlin D. E., Griggs R. C. Treatment of inflammatory myopathies with azathioprine. Trans Am Neurol Assoc. 1968;93:244–246. [PubMed] [Google Scholar]
  48. Medsger T. A., Jr, Robinson H., Masi A. T. Factors affecting survivorship in polymyositis. A life-table study of 124 patients. Arthritis Rheum. 1971 Mar-Apr;14(2):249–258. doi: 10.1002/art.1780140210. [DOI] [PubMed] [Google Scholar]
  49. Metzger A. L., Bohan A., Goldberg L. S., Bluestone R., Pearson C. M. Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. Ann Intern Med. 1974 Aug;81(2):182–189. doi: 10.7326/0003-4819-81-2-182. [DOI] [PubMed] [Google Scholar]
  50. Metzger A. L., Singer F. R., Bluestone R., Pearson C. M. Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. N Engl J Med. 1974 Dec 12;291(24):1294–1296. doi: 10.1056/NEJM197412122912408. [DOI] [PubMed] [Google Scholar]
  51. Miller J. J., 3rd Late progression in dermatomyositis in childhood. J Pediatr. 1973 Oct;83(4):543–548. doi: 10.1016/s0022-3476(73)80212-4. [DOI] [PubMed] [Google Scholar]
  52. Nishikai M., Homma M. Circulating autoantibody against human myoglobin in polymyositis. JAMA. 1977 Apr 25;237(17):1842–1844. [PubMed] [Google Scholar]
  53. Park S., Nyhan W. L. Fatal pulmonary involvement in dermatomyositis. Am J Dis Child. 1975 Jun;129(6):723–726. doi: 10.1001/archpedi.1975.02120430057016. [DOI] [PubMed] [Google Scholar]
  54. Pearson C. M. Treatment of polymyositis and dermatomyositis. Mod Treat. 1966 Nov;3(6):1302–1311. [PubMed] [Google Scholar]
  55. Rose A. L. Childhood polymyositis. A follow-up study with special reference to treatment with corticosteroids. Am J Dis Child. 1974 Apr;127(4):518–522. doi: 10.1001/archpedi.1974.02110230064009. [DOI] [PubMed] [Google Scholar]
  56. Rose A. L., Walton J. N. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis. Brain. 1966 Dec;89(4):747–768. doi: 10.1093/brain/89.4.747. [DOI] [PubMed] [Google Scholar]
  57. SCHUERMANN H. Maligne tumoren bei Dermatomyositis und progressiver Sklerodermie. Arch Dermatol Syph. 1951;192(6):575–582. [PubMed] [Google Scholar]
  58. SHY G. M. The late onset myopathy. A clinicopathologic study of 131 patients. World Neurol. 1962 Feb;3:149–160. [PubMed] [Google Scholar]
  59. Samitz M. H. Cuticular changes in dermatomyositis. A clinical sign. Arch Dermatol. 1974 Dec;110(6):866–867. [PubMed] [Google Scholar]
  60. Sanger R. G., Kirby J. W. The oral and facial manifestations of dermatomyositis with calcinosis. Report of a case. Oral Surg Oral Med Oral Pathol. 1973 Apr;35(4):476–488. doi: 10.1016/0030-4220(73)90005-4. [DOI] [PubMed] [Google Scholar]
  61. Sarmiento A. H., Alba J., Lanaro A. E., Dietrich R. Evaluation of soft-tissue calcifications in dermatomyositis with 99mTc-phosphate compounds: case report. J Nucl Med. 1975 Jun;16(6):467–468. [PubMed] [Google Scholar]
  62. Sato T., Walker D. L., Peters H. A., Resse H. H., Chou S. M. Chronic polymyositis and myxovirus-like inclusions. Electron microscopic and viral studies. Arch Neurol. 1971 May;24(5):409–418. doi: 10.1001/archneur.1971.00480350043004. [DOI] [PubMed] [Google Scholar]
  63. Schaumburg H. H., Nielsen S. L., Yurchak P. M. Heart block in polymyositis. N Engl J Med. 1971 Mar 4;284(9):480–481. doi: 10.1056/NEJM197103042840905. [DOI] [PubMed] [Google Scholar]
  64. Schein P. S., Winokur S. H. Immunosuppressive and cytotoxic chemotherapy: long-term complications. Ann Intern Med. 1975 Jan;82(1):84–95. doi: 10.7326/0003-4819-82-1-84. [DOI] [PubMed] [Google Scholar]
  65. Schwarz M. I., Matthay R. A., Sahn S. A., Stanford R. E., Marmorstein B. L., Scheinhorn D. J. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976 Jan;55(1):89–104. doi: 10.1097/00005792-197601000-00005. [DOI] [PubMed] [Google Scholar]
  66. Steiner R. M., Glassman L., Schwartz M. W., Vanace P. The radiological findings in dermatomyositis of childhood. Radiology. 1974 May;111(2):385–393. doi: 10.1148/111.2.385. [DOI] [PubMed] [Google Scholar]
  67. Sullivan D. B., Cassidy J. T., Petty R. E., Burt A. Prognosis in childhood dermatomyositis. J Pediatr. 1972 Apr;80(4):555–563. doi: 10.1016/s0022-3476(72)80050-7. [DOI] [PubMed] [Google Scholar]
  68. Susac J. O., Garcia-Mullin R., Glaser J. S. Ophthalmoplegia in dermatomyositis. Neurology. 1973 Mar;23(3):305–310. doi: 10.1212/wnl.23.3.305. [DOI] [PubMed] [Google Scholar]
  69. THIERSCH J. B. Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route. Am J Obstet Gynecol. 1952 Jun;63(6):1298–1304. doi: 10.1016/s0002-9378(16)38924-4. [DOI] [PubMed] [Google Scholar]
  70. Thompson C. E. Polymyositis in children. Clin Pediatr (Phila) 1968 Jan;7(1):24–28. doi: 10.1177/000992286800700109. [DOI] [PubMed] [Google Scholar]
  71. Urich H., Wilkinson M. Necrosis of muscle with carcinoma: myositis or myopathy? J Neurol Neurosurg Psychiatry. 1970 Jun;33(3):398–407. doi: 10.1136/jnnp.33.3.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Vanderploeg D. E. Dermatomyositis and Malignancy. Cutis. 1977 Feb;19(2):205–207. [PubMed] [Google Scholar]
  73. Vignos P. J., Jr, Goldwyn J. Evaluation of laboratory tests in diagnosis and management of polymyositis. Am J Med Sci. 1972 Apr;263(4):291–308. doi: 10.1097/00000441-197204000-00012. [DOI] [PubMed] [Google Scholar]
  74. WEDGWOOD R. J., COOK C. D., COHEN J. Dermatomyositis; report of 26 cases in children with a discussion of endocrine therapy in 13. Pediatrics. 1953 Oct;12(4):447–466. [PubMed] [Google Scholar]
  75. Warne G. L., Fairley K. F., Hobbs J. B., Martin F. I. Cyclophosphamide-induced ovarian failure. N Engl J Med. 1973 Nov 29;289(22):1159–1162. doi: 10.1056/NEJM197311292892202. [DOI] [PubMed] [Google Scholar]
  76. Whitaker J. N., Engel W. K. Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med. 1972 Feb 17;286(7):333–338. doi: 10.1056/NEJM197202172860701. [DOI] [PubMed] [Google Scholar]
  77. Winkelmann R. K., Mulder D. W., Lambert E. H., Howard F. M., Jr, Diessner G. R. Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients. Mayo Clin Proc. 1968 Aug;43(8):545–556. [PubMed] [Google Scholar]
  78. Wolfe J. F., Adelstein E., Sharp G. C. Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest. 1977 Jan;59(1):176–178. doi: 10.1172/JCI108616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Zilko P. J., Dawkins R. L. Amyloidosis associated with dermatomyositis and features of multiple myeloma. The progression of amyloidosis associated with corticosteroid and cytotoxic drug therapy. Am J Med. 1975 Sep;59(3):448–452. doi: 10.1016/0002-9343(75)90406-4. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES